NCT02673047已完成不适用
Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 474
- 试验地点
- 50
- 主要终点
- Target Patients Prescribed Botox® in Clinical Practice
研究概览
简要总结
This study will describe the prescription conditions of botulinum toxin Type A (Botox®) injection for the treatment of urinary incontinence due to neurogenic detrusor overactivity (NDO) or idiopathic overactive bladder (IOAB) as per standard of care in clinical practice in France.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who receive a Botox® injection for urinary incontinence.
排除标准
- •Patients not residing in France.
结局指标
主要结局
Target Patients Prescribed Botox® in Clinical Practice
时间窗: Day 1
次要结局
- Types of Anaesthesia and Antibiotic Prophylaxis Used(Day 1)
- Cytobacteriological Examination of the Urine(Day 1)
- Total Number of Botox® Cycles in Non-naive Patients (previously received Botox®)(Day 1)
- Length of Botox® Treatment in Non-naive Patients(Day 1)
- Time Since Last Botox® Injection in Non-naive Patients(Day 1)
- Characteristics of Injector Sites (Locations)(Day 1)
- Total Dose of Botox® Used(Day 1)
- Treatments Previously Prescribed(Day 1)
- Number of Sites Injected(Day 1)
- Characteristics of Injector Physicians(Day 1)
- Characteristics of Patients(Day 1)
- Number of Patients by Pathology History(Day 1)
- Number of Patients by Medical and Surgical History(Day 1)
- Reduction of Number of Daily Urinary Incontinence Episodes in Non-naive Patients(Day 1)
- Percentage of Continent Patients in Non-naive Patients(Day 1)
- Number of Adverse Events during the Visit(Day 1)
研究者
研究点 (50)
Loading locations...
相似试验
尚未招募
3 期
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's DiseaseBuerger DiseaseRaynaud SyndromeNCT05698979University Hospital, Toulouse8
终止
4 期
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's DiseaseParkinson DiseaseNCT00477802University of Cincinnati8
终止
2 期
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive BladderOveractive BladderNCT00578097Ipsen81
已完成
早期 1 期
Evaluation of BOTOX® With Rehabilitation Therapy for the Treatment of Wrist and Hand Spasticity in Post-Stroke PatientsStrokeNCT00565201Emory University25
已完成
3 期
Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary IncontinenceOveractive BladderNCT00910845Allergan557